https://www.crowell.com/en/insights/client-alerts/after-trump-executive-orders-fda-removes-diversity-guidance-from-website

Days after President Trump issued an executive order (EO) taking aim at diversity, equity, and inclusion (DEI) programs and prohibiting federal recognition of gender identity apart from biological sex, previously issued draft guidance on diversity in clinical trials was removed from the website of the U.S. Food and Drug Administration (FDA).